MedTrace Logo

HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke

NCT06316557 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-07-02

No results posted yet for this study

Summary

The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days.

Conditions

Interventions

DEVICE

iTBS group

iTBS on the contralesional cerebellum, twice a day for seven days

DEVICE

control group

shame stimulation on the contralesional cerebellum, twice a day for seven days

Sponsors & Collaborators

  • Zi-Xiao Li

    lead OTHER

Principal Investigators

  • Zixiao LI, Dr. · Beijing Tiantan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-07-01
Completion
2027-04-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06316557 on ClinicalTrials.gov